Archives 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 February 29, 2012 ImmuPharma PLC Appoints Head of Investor Relations Read More November 03, 2011 ImmuPharma’s Lupuzor™ given approval to start phase III and Fast Track designation by the FDA Read More October 21, 2011 ImmuPharma regains Lupuzor rights from Cephalon due to Teva merger Read More 1…151617
November 03, 2011 ImmuPharma’s Lupuzor™ given approval to start phase III and Fast Track designation by the FDA Read More
